Remdesivir for patients hospitalised with COVID-19 (adults and children aged 12 years and older) – Supply Disruption

Due to increased demand against available supply, clinicians are now asked to apply the full eligibility criteria as set out within interim clinical commissioning policy published 3 July 2020. Clinicians are also asked to adhere to a standard treatment course of 5 days.

Department of Health and Social Care